Inhibition of human killer cells by autologous lymphocytes
Pollack, S.B.; Emmons, S.I.
Journal of Immunology 122(2): 718-722
1979
ISSN/ISBN: 0022-1767 PMID: 310849 Document Number: 151960
Human antibody cells in the absence of added Ab is not inhibited by the FcR-depleted population, indicating that K and NK cells differ from each other in this respect.
Document emailed within 1 workday
Related Documents
Bensussan, A.; Lagabrielle, J.F.; Castaigne, S.; Boisson, N.; Miclea, J.M.; Benbunan, M.; Degos, L. 1989: Human CD3 gamma delta + activated lymphocytes exhibit killer activity in vitro against autologous leukemic cells Nouvelle Revue Francaise d'Hematologie 31(2): 129-132Itoh, K.; Tilden, A.B.; Balch, C.M. 1985: Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells Cancer Research 45(7): 3173-3178
Torok-Storb, B.; Graf, L.; Shankar, P. 1989: Inhibition of erythroid progenitor growth is mediated by cytotoxic lymphocytes and not by natural killer cells or IFN-gamma Journal of Immunology 143(6): 1837-1842
Cheknev, S.B.; Ershov, F.I.; Pritsker, A.D.; Latysheva, O.L. 1994: Regulation of the activity of human natural killer cells by autologous interferon Biulleten' Eksperimental'noi Biologii i Meditsiny 118(9): 281-284
Baral, E.; Nagy, E.; Krepart, G.V.; Lotocki, R.J.; Unruh, H.W.; Berczi, I. 2000: Antiestrogens sensitize human ovarian and lung carcinomas for lysis by autologous killer cells Anticancer Research 20(3b): 2027-2031
Shi, M.; Yao, L.; Wang, F-Sheng.; Lei, Z-Yun.; Zhang, B.; Li, W-Liang.; Liu, J-Chao.; Tang, Z-Rong.; Zhou, G-de. 2004: Growth inhibition of human hepatocellular carcinoma xenograft in nude mice by combined treatment with human cytokine-induced killer cells and chemotherapy Zhonghua Zhong Liu Za Zhi 26(8): 465-468
Itoh, K.; Tilden, A.B.; Kumagai, K.; Balch, C.M. 1985: Leu-11+ lymphocytes with natural killer (NK) activity are precursors of recombinant interleukin 2 (rIL 2)-induced activated killer (AK) cells Journal of Immunology 134(2): 802-807
Csako, G.; Binder, R.A.; Kales, A.N.; Neefe, J.R. 1980: Cloning of human lymphocytes reactive with autologous leukemia cells Cancer Research 40(9): 3218-3221
Thiele, D.L.; Lipsky, P.E. 1986: Leu-Leu-OMe sensitivity of human activated killer cells: delineation of a distinct class of cytotoxic T lymphocytes capable of lysing tumor targets Journal of Immunology 137(4): 1399-1406
Satoh, M.; Seki, S.; Hashimoto, W.; Ogasawara, K.; Kobayashi, T.; Kumagai, K.; Matsuno, S.; Takeda, K. 1996: Cytotoxic gammadelta or alphabeta T cells with a natural killer cell marker, CD56, induced from human peripheral blood lymphocytes by a combination of IL-12 and IL-2 Journal of Immunology 157(9): 3886-3892
Lee, S.H.; Kelley, S.; Chiu, H.; Stebbing, N. 1982: Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes Cancer Research 42(4): 1312-1316
Weisbart, R.H.; Lusis, A.J.; Chan, G.; Billing, R.; Ashman, R.F.; Golde, D.W. 1982: Neutrophil migration inhibition factor from T lymphocytes (NIF-T): selective removal of biologic activity by human peripheral blood neutrophils, myelocytic leukemia cells, and differentiated HL-60 cells Journal of Immunology 128(1): 457-462
Yanagisawa, M.; Kato, M.; Ikeno, K.; Kobayashi, T.; Miyagawa, Y.; Komiyama, A.; Akabane, T. 1987: Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection Clinical and Experimental Immunology 68(2): 251-258
Maeda, M.; Fujii, T.; Terao, T. 1987: Cytotoxicity of T-lymphocytes from a patient with choriocarcinoma to autologous tumor cultured cells--stimulation with the husband's lymphocytes Nihon Sanka Fujinka Gakkai Zasshi 39(2): 256-262
Santin, A.D.; Hermonat, P.L.; Ravaggi, A.; Bellone, S.; Cowan, C.; Korourian, S.; Pecorelli, S.; Cannon, M.J.; Parham, G.P. 2000: Development, characterization and distribution of adoptively transferred peripheral blood lymphocytes primed by human papillomavirus 18 E7--pulsed autologous dendritic cells in a patient with metastatic adenocarcinoma of the uterine cervix European Journal of Gynaecological Oncology 21(1): 17-23
Guo, Y.S.; Xing, Z.L. 1994: A study of the cytotoxicity of malignant pleural effusion lymphocytes and LAK cells against autologous tumor cells Chinese Medical Journal 107(12): 903-905
Timofeev, I.V.; Kuznetsov, V.P.; Slavina, E.G.; Timofeeva, T.P.; Orlova, T.G. 1982: Effect of various forms of human leukocyte interferon on the natural killer activity of human lymphocytes Antibiotiki 27(10): 782-784
Shirakawa, F.; Tanaka, Y.; Eto, S.; Suzuki, H.; Yodoi, J.; Yamashita, U. 1986: Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells) Journal of Immunology 137(2): 551-556
Ali, N.A.; Lüdtke, J.; Pilgrim, H.; Lindequist, U. 1996: Inhibition of chemiluminescence response of human mononuclear cells and suppression of mitogen-induced proliferation of spleen lymphocytes of mice by hispolon and hispidin Die Pharmazie 51(9): 667-670
Su, H.-b.; Li, H.-w.; Zhao, H.-l.; Shi, M.; Zhang, B.; Tang, Z.-r.; Lei, Z.-y.; Wang, H.-f.; Wang, F.-s. 2007: Therapeutic effect of autologous cytokine-induced killer cells on patients with liver cirrhosis caused by HBV infection Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 21(1): 64-66